Biocept

^{Priced, Nasdaq: BIOC}

Develops and markets cancer diagnostic tests.

Industry: Health Care

First Day Return: -6.0%

BIOC

Develops and markets cancer diagnostic tests.

IPO News for Biocept

Biocept prices IPO at $10, the low end of the range 02/05/14
12 US IPOs planned for the week of Feb 3 02/03/14
US IPO Recap: Chinese IPOs continue their strong run 11/25/13

IPO Data
IPO Date	02/04/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$19
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.biocept.com
Headquarters	San Diego, CA, United States
Founded	1997
Employees at IPO	27

IPO News for Biocept

Biocept prices IPO at $10, the low end of the range 02/05/14
12 US IPOs planned for the week of Feb 3 02/03/14
US IPO Recap: Chinese IPOs continue their strong run 11/25/13

Biocept (BIOC) Performance